Taj-Addin Nasser, MD
Ophthalmology · Irving, TXNPI 1487158150
Payments from drug & device makers
Across 207 payments — averaging $99.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$4K
- Lumibird Medical Inc.$4K
- Tarsus Pharmaceuticals, Inc.$3K
- Rxsight Inc$3K
- AbbVie$2K
- Bausch & Lomb Americas Inc.$1K
- plus $4K from 21 others
What the payments were for
- Consulting fees$8,03039%
- Speaking & faculty fees$2,90114%
- Food & beverage$9,36945%
- Education$1611%
- Entertainment$1761%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 55 | $4,397 |
| Lumibird Medical Inc. | 2 | $3,750 |
| Tarsus Pharmaceuticals, Inc. | 15 | $2,793 |
| Rxsight Inc | 18 | $2,731 |
| AbbVie(2 entities) | 17 | $1,775 |
| Bausch & Lomb Americas Inc. | 12 | $1,387 |
| Glaukos Corporation | 18 | $930 |
| Lensar, Inc. | 3 | $711 |
| Johnson & Johnson Surgical Vision, Inc. | 10 | $323 |
| Carl Zeiss Meditec USA, Inc. | 2 | $279 |
| Biotissue Holdings Inc. | 14 | $254 |
| Oyster Point Pharma, Inc. | 5 | $206 |
| Rayner Intraocular Lenses Limited | 7 | $185 |
| Optos, Inc. | 3 | $176 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $108 |
| Sight Sciences, Inc. | 3 | $98 |
| Aerie Pharmaceuticals, Inc. | 1 | $94 |
| Beaver-visitec International, Inc. | 2 | $92 |
| Ocular Therapeutix, Inc. | 4 | $82 |
| Novartis | 4 | $62 |
| Sun Pharmaceutical Industries Inc. | 2 | $52 |
| Thea Pharma Inc. | 2 | $48 |
| Harrow Eye, LLC | 2 | $41 |
| GSK | 1 | $19 |
| Oasis Medical, Inc. | 1 | $16 |
| Heidelberg Engineering, Inc. | 1 | $15 |
| Tearlab Corp | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RXSIGHT CONTACT LENS$2,236
- RXSIGHT INJECTOR CARTRIDGE$2,236
- LIGHT ADJUSTABLE LENS (LAL)$2,236
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$2,236
- RXSIGHT INJECTOR HANDPIECE$2,236
- Wavelight Refractive Suite$1,618
- TANGO OPTIMO$1,250
- ENVISTA ENVY IOL$1,150
- LENSAR LASER SYSTEM$697
- XDEMVY$361
- OCT OPHTHALMOSCOPE$268
- PANORAMIC OPHTHALMOSCOPE$268
- Clareon$250
- VisuMax$187
- NFC-700$134
- Tecnis IOL$130
- Hydrus Microstent$120
- LUMIGAN$118
- KXL System$116
- Photrexa$116
How this compares
$20,636 in reported general payments places this provider in the 85th percentile of 1,355 ophthalmology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 19 | $1,007 |
| Ketorolac Tromethamine | 13 | $426 |
| MoxifloxacinMoxifloxacin Hcl | 14 | $290 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Irving
- Charles WykoffBellaire$73.4M
- David BrownHouston$51.7M
- Sunil PatelAbilene$11.1M
- Chirag JhaveriAustin$9.4M
- Robert WongAustin$6.6M
- Fuad MakkoukAustin$6.6M
- Patrick WilliamsArlington$6.6M
- Ashkan AbbeyDallas$5.7M
- Karl CsakyDallas$4.9M
- Michael SingerSan Antonio$4.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.